Search Results | Blood | American Society of Hematology

1-20 of 150

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Development and Validation of a Prognostic Model for Transplant-Associated Thrombotic Microangiopathy Following Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2020) 136 (Supplement 1): 16–17.

DOI: https://doi.org/10.1182/blood-2020-138408

Published: 2020

Journal Articles

Both the Subtypes of Kit Mutation and Minimal Residual Disease Are Associated with Prognosis in Core Banding Factor Acute Myeloid Leukemia

Wenbing Duan, Xiaohong Liu, Jinsong JIA, MDPhD, Jing Wang, MD, Lizhong Gong, Qian Jiang, MD, Ting Zhao, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiaosu Zhao, PhD, Yazhen Qin, Hongxia Shi, Yingjun Chang, Xiaojun Huang, Hao Jiang, MD

Blood (2020) 136 (Supplement 1): 4–5.

DOI: https://doi.org/10.1182/blood-2020-141905

Published: 2020

Journal Articles

M2 Macrophages, but Not M1 Macrophages, Support Megakaryopoiesis Via up-Regulating PI3K-AKT Pathway

Hong-Yan Zhao, PhD, Qi Wen, MD, Zhong-Shi Lyu, Shu-Qian Tang, Yuan-Yuan Zhang, Meng Lyu, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Yuan Kong, Xiao-Jun Huang

Blood (2020) 136 (Supplement 1): 1.

DOI: https://doi.org/10.1182/blood-2020-136562

Published: 2020

Journal Articles

Different Subsets of Haematopoietic Cells and Immune Cells in Bone Marrow between Young and Old Donors

Weili Yao, Qi Wen, MD, Hong-Yan Zhao, PhD, Yuan-Yuan Zhang, Shuqian Tang, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao Jun Huang, Yuan Kong

Blood (2020) 136 (Supplement 1): 33–34.

DOI: https://doi.org/10.1182/blood-2020-134758

Published: 2020

Journal Articles

This Is a Title: Single-Center Data Report of Clhag Regimen for R/R-AML Patients

Chuanyan Jiang, Yu Wang, Mengying Zou, Yijing Wang, Jun Wang, Jiafei Wu, Xi Yang, Hui LI, MD

Blood (2020) 136 (Supplement 1): 3.

DOI: https://doi.org/10.1182/blood-2020-139708

Published: 2020

Journal Articles

This Is a Title: Cytarabine Combined with PD-1 Inhibitor in the Treatment of R/R-AML: A Report of 3 Cases and Literature Review

Yu Wang, Chuanyan Jiang, Xi Yang, Jingying Dai, PhD, Mengying Zou, Yijing Wang, Jun Wang, Jiafei Wu, Hui LI, MD

Blood (2020) 136 (Supplement 1): 26.

DOI: https://doi.org/10.1182/blood-2020-139729

Published: 2020

Journal Articles

Mutations Based on Next-Generation Sequencing May be Complementally to Prognostic Risk in Myelodysplastic Syndromes

Jing Wang, MD, Jinsong Jia, Xiaohong Liu, Lizhong Gong, Shengye Lu, Yu Wang, Lanping Xu, Xiaohui Zhang, Chenhua Yan, Yueyun Lai, Xiaosu Zhao, PhD, Yazhen Qin, Guorui Ruan, Yingjun Chang, Hongxia Shi, Kaiyan Liu, Xiaojun Huang, Hao Jiang, MD

Blood (2020) 136 (Supplement 1): 42–43.

DOI: https://doi.org/10.1182/blood-2020-140977

Published: 2020

Journal Articles

The Prognostic Significance of Wilms' Tumor Gene 1 in Adult AML with Different Risk Stratification Following Allo-HSCT

Ke Wang, Songhai Zhou, Yuqian Sun, MD, Chenhua Yan, Yu Wang, Xiaojun Huang, MD, Xiaosu Zhao, PhD

Blood (2020) 136 (Supplement 1): 4–5.

DOI: https://doi.org/10.1182/blood-2020-139026

Published: 2020

Journal Articles

M1 and M2 Macrophages Play Different Roles in the Pathogenesis of Acute Graft-Versus-Host Disease Post-Allotransplant By Modulating Immune Microenvironment

Qi Wen, MD, Hong-Yan Zhao, PhD, Zhong-Shi Lyu, Yao Weili, Ting-Ting Han, Yu-Hong Chen, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Yuan Kong, Xiao-Jun Huang

Blood (2020) 136 (Supplement 1): 19–20.

DOI: https://doi.org/10.1182/blood-2020-136021

Published: 2020

Journal Articles

Long-Term Follow-up of a Randomized Trial of Two Dose Levels of Antithymocyte Globulin in Haploidentical Hematopoietic Stem Cell Transplantation

Yu Wang, Ren Lin, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Qi-Fa Liu, Xiao-Jun Huang

Blood (2020) 136 (Supplement 1): 20.

DOI: https://doi.org/10.1182/blood-2020-139063

Published: 2020

Journal Articles

Results from a Phase 1 Dose Escalation Study of HMPL-689, a Selective Oral Phosphoinositide 3-Kinase-Delta Inhibitor, in Chinese Patients with Relapsed/Refractory (R/R) Lymphomas

Junning Cao, Zhiming Li, MD PhD, Jianfeng Zhou, MD PhD, Dongmei Ji, MD PhD, Weina Shen, PhD, Peng Sun, MD, Yu Wang, MD, Dengju Li, MD, Zhenya Hong, MDPhD, Gaoxiang Wang, MDPhD, Xianlin Duan, MD, Chen Yu, MD, Yu Cai, PhD, Weiguo Su, PhD

Blood (2020) 136 (Supplement 1): 38.

DOI: https://doi.org/10.1182/blood-2020-136013

Published: 2020

Journal Articles

FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD + acute myeloid leukemia

Blood (2020) 135 (17): 1472–1483.

DOI: https://doi.org/10.1182/blood.2019003538

Published: 2020

Includes: Supplemental data

Journal Articles

Erythroferrone lowers hepcidin by sequestering BMP2/6 heterodimer from binding to the BMP type I receptor ALK3

Chia-Yu Wang, Yang Xu, Lisa Traeger, Deniz Y. Dogan, Xia Xiao, Andrea U. Steinbicker, Jodie L. Babitt

Blood (2020) 135 (6): 453–456.

DOI: https://doi.org/10.1182/blood.2019002620

Published: 2020

Includes: Supplemental data

Journal Articles

Autophagy in Endothelial Cells Regulates Their Hematopoiesis Supporting Ability

Yuan Kong, MD PhD, Xie-Na Cao, Zhong-Shi Lyu, PhD, Xiao-Dong Mo, Qi Wen, MD, Hong-Yan Zhao, MD, Yu-Hong Chen, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang

Blood (2019) 134 (Supplement_1): 4425.

DOI: https://doi.org/10.1182/blood-2019-122227

Published: 2019

Journal Articles

Donor and Host Coexpressing KIR Ligands Promote NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Xingxing Yu, Xiang-Yu Zhao, Zhengli Xu, Xunhong Cao, Mingrui Huo, Xiao-Su Zhao, Ying-Jun Chang, Yu Wang, Xiaohui Zhang, Lanping Xu, Kaiyan Liu, Xiaojun Huang, MD

Blood (2019) 134 (Supplement_1): 4519.

DOI: https://doi.org/10.1182/blood-2019-129609

Published: 2019

Journal Articles

Efficacy and Safety Evaluation of Elderly Patients with AML Based on Clinical Common Chemotherapy Regimens Under Real-World Events

Yu Wang, Mengying Zou, Xi Yang, Li Hui, Hong Zheng, MD PhD

Blood (2019) 134 (Supplement_1): 5109.

DOI: https://doi.org/10.1182/blood-2019-128608

Published: 2019

Journal Articles

Rituximab for Desensitization during HLA-Mismatched Stem Cell Transplantation in Patients with a Positive Donor Specific Anti-HLA Antibody: A Prospective Study

Ying-Jun Chang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chenhua Yan, Fei-Fei Tang, Ming-Rui Huo, Xiao-Dong Mo, MD, Xiang-Yu Zhao, Kai-yan Liu, Xiao-Jun Huang

Blood (2019) 134 (Supplement_1): 5622.

DOI: https://doi.org/10.1182/blood-2019-129781

Published: 2019

Journal Articles

Ruxolitinib Is an Effective Salvage Treatment for Multidrug-Resistant Graft-Versus-Host Disease after Allogeneic Hematopoietic Transplantation

Sining Liu, Jiaoyu Zhao, Lanping Xu, Xiaohui Zhang, MD, Yu Wang, Yuhong Chen, Kaiyan Liu, Xiaojun Huang, Xiaodong Mo

Blood (2019) 134 (Supplement_1): 5670.

DOI: https://doi.org/10.1182/blood-2019-126278

Published: 2019

Journal Articles

Disease Risk Comorbidity Index for Patients Receiving Haploidentical Allogeneic Hematopoietic Transplantation

Xiaodong Mo, Xiaohui Zhang, MD, Lanping Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Sining Liu, Kaiyan Liu, Xiaojun Huang

Blood (2019) 134 (Supplement_1): 5716.

DOI: https://doi.org/10.1182/blood-2019-124371

Published: 2019

Journal Articles

Preemptive Therapy Based on the Load and Time of EBV-Emia for Preventing EBV Related PTLD after Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective Multicenter Study

Can Liu, Ren Lin, Yu Wang, Fen Huang, MD, Zhiping Fan, MD, Shen Zhang, Yajing Xu, MD PhD, Ting Yang, Li Xuan, MD, Na Xu, Jieyu Ye, MD PhD, Jing Sun, Xiaojun Huang, MD, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 5693.

DOI: https://doi.org/10.1182/blood-2019-132106

Published: 2019

2 3 4 5

NARROW

Development and Validation of a Prognostic Model for Transplant-Associated Thrombotic Microangiopathy Following Allogeneic Hematopoietic Stem Cell Transplantation

Both the Subtypes of Kit Mutation and Minimal Residual Disease Are Associated with Prognosis in Core Banding Factor Acute Myeloid Leukemia

M2 Macrophages, but Not M1 Macrophages, Support Megakaryopoiesis Via up-Regulating PI3K-AKT Pathway

Different Subsets of Haematopoietic Cells and Immune Cells in Bone Marrow between Young and Old Donors

This Is a Title: Single-Center Data Report of Clhag Regimen for R/R-AML Patients

This Is a Title: Cytarabine Combined with PD-1 Inhibitor in the Treatment of R/R-AML: A Report of 3 Cases and Literature Review

Mutations Based on Next-Generation Sequencing May be Complementally to Prognostic Risk in Myelodysplastic Syndromes

The Prognostic Significance of Wilms' Tumor Gene 1 in Adult AML with Different Risk Stratification Following Allo-HSCT

M1 and M2 Macrophages Play Different Roles in the Pathogenesis of Acute Graft-Versus-Host Disease Post-Allotransplant By Modulating Immune Microenvironment

Long-Term Follow-up of a Randomized Trial of Two Dose Levels of Antithymocyte Globulin in Haploidentical Hematopoietic Stem Cell Transplantation

Results from a Phase 1 Dose Escalation Study of HMPL-689, a Selective Oral Phosphoinositide 3-Kinase-Delta Inhibitor, in Chinese Patients with Relapsed/Refractory (R/R) Lymphomas

FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD + acute myeloid leukemia

Erythroferrone lowers hepcidin by sequestering BMP2/6 heterodimer from binding to the BMP type I receptor ALK3

Autophagy in Endothelial Cells Regulates Their Hematopoiesis Supporting Ability

Donor and Host Coexpressing KIR Ligands Promote NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Efficacy and Safety Evaluation of Elderly Patients with AML Based on Clinical Common Chemotherapy Regimens Under Real-World Events

Rituximab for Desensitization during HLA-Mismatched Stem Cell Transplantation in Patients with a Positive Donor Specific Anti-HLA Antibody: A Prospective Study

Ruxolitinib Is an Effective Salvage Treatment for Multidrug-Resistant Graft-Versus-Host Disease after Allogeneic Hematopoietic Transplantation

Disease Risk Comorbidity Index for Patients Receiving Haploidentical Allogeneic Hematopoietic Transplantation

Preemptive Therapy Based on the Load and Time of EBV-Emia for Preventing EBV Related PTLD after Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective Multicenter Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only